Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Wattanapat Hospital Trang Public Company Limited (WPH.BK)
Trang, TH
Wattanapat Hospital Trang Public Company Limited is a healthcare provider managing a network of hospitals and clinics across Thailand. Its comprehensive medical facilities deliver a broad spectrum of specialized services, encompassing areas such as obstetrics and gynecology, various surgical procedures, internal medicine, pediatrics, neurology, cardiology, ophthalmology, and otolaryngology (ENT). Furthermore, the company offers dermatology and aesthetic treatments, dental services, a dedicated wellness center, and sophisticated diagnostic imaging capabilities including X-ray and MRI. Emergency care is readily available through both its WPH-branded and general emergency centers. Specialized clinics are also provided for conditions related to kidney and hemodialysis, physical therapy, gastroenterology, orthopedics, and endocrinology (diabetes and thyroid disorders). Established in 1957, the organization maintains its headquarters in Trang, Thailand.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +2.68% | -16.06% | +5.12% | -4.96% | -26.47% | +65.71% | +230.46% | +65.71% | +65.71% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2025-09 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+14.7% ★ Q1'26: +10.5% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+21.4% ★ Q1'26: +10.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+12.5% Q1'26: +3.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+19.1% ★ Q1'26: +28.6% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+12.0% ★ Q1'26: +23.5% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+3.6% Q1'26: -2.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.03× Q1'26: 1.11× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|
| Revenue |
2.03B
est: 2.08B (-2.3%)
|
2.33B
est: 2.38B (-2.0%)
|
2.97B
2.97B – 2.97B
+24.9% YoY
|
| EBITDA |
532.73M
est: 508.06M (+4.9%)
|
610.44M
est: 580.88M (+5.1%)
|
725.31M
725.31M – 725.31M
+24.9% YoY
|
| EBIT |
382.58M
est: 359.31M (+6.5%)
|
444.28M
est: 410.81M (+8.1%)
|
512.95M
512.95M – 512.95M
+24.9% YoY
|
| Net Income |
278.85M
est: 311.70M (-10.5%)
|
351.76M
est: 351.76M (0.0%)
|
455.22M
455.22M – 455.22M
+29.4% YoY
|
| SGA |
266.58M
est: 287.25M (-7.2%)
|
325.31M
est: 328.42M (-0.9%)
|
410.08M
410.08M – 410.08M
+24.9% YoY
|
| EPS |
0.41
est: 0.44 (-7.1%)
|
0.50
est: 0.50 (+0.0%)
|
0.65
0.65 – 0.65
+29.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Amara Leelawat | Executive Vice Chairman | 248.3K | female |
| Chane Laosonthorn | Executive VP & Executive Director | 248.3K | male |
| Chen Laosunthorn | Director and Deputy Director for Finance Department | 248.3K | male |
| Pinit Laosunthorn | Executive Director | 218.3K | male |
| Pornlert Boonsontisuk | Executive Director | 218.3K | male |
| Somchai Chansawang | CEO & Executive Director | 218.3K | — |
| Tipparat Khaimarn | Head of the Compliance Unit & Company Secretary | — | female |
| Wirawit Wannaruk | Accounting & Finance Manager and Accounting Supervisor | — | male |
| Supanun Aramay | Hospital Director | — | female |
| Paisan Puratjaroenchai | Head of Internal Audit | — | male |
| Mantanee Rattamanee | Head of Investor Relations | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for WPH.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
